Annie Peytier
Centre Hospitalier de la Côte Basque(FR)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Lung Cancer Diagnosis and Treatment, Liver Disease Diagnosis and Treatment, Lung Cancer Treatments and Mutations, Lymphoma Diagnosis and Treatment
Most-Cited Works
- → Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)(2020)164 cited
- → Gemcitabine and Paclitaxel Versus Gemcitabine Alone After 5-Fluorouracil, Oxaliplatin, and Irinotecan in Metastatic Pancreatic Adenocarcinoma: A Randomized Phase III PRODIGE 65-UCGI 36-GEMPAX UNICANCER Study(2024)31 cited
- [Chronic cirrhogenic hepatitis induced by germander].(1993)
- → Utility of serum anti‐cetuximab immunoglobulin E levels to identify patients at a high risk of severe hypersensitivity reaction to cetuximab(2016)22 cited
- → LIBELULE: A randomized phase III study to evaluate the clinical relevance of early liquid biopsy (LB) in patients with suspicious metastatic lung cancer.(2023)14 cited
- → LIBELULE: A Randomized Phase III Study to Evaluate the Clinical Relevance of Early Liquid Biopsy in Patients With Suspicious Metastatic Lung Cancer(2024)10 cited
- → 1566TiP PRODIGE 65 - UCGI 36 - GEMPAX : A unicancer phase III randomized study evaluating gemcitabine and paclitaxel versus gemcitabine alone after FOLFIRINOX failure or intolerance in metastatic pancreatic ductal adenocarcinoma(2020)4 cited
- CHRONIC ACTIVE HEPATITIS PROGRESSING TO CIRRHOSIS AFTER GERMANDER ADMINISTRATION GASTROENTEROL(1993)
- [Acute ischemia of the small intestine in a long-distance runner].(1995)
- [Acute pancreatitis and propylthiouracil].(1995)